Filtros de búsqueda

Lista de obras de

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016.

artículo científico publicado en 2016

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016

artículo científico publicado en 2016

A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer

artículo científico publicado en 2020

A bloody mess: dendritic cells use hemophagocytosis to regulate viral inflammation

artículo científico publicado en 2013

A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy

artículo científico publicado en 2002

A conserved dendritic-cell regulatory program limits antitumour immunity

scientific article published on 25 March 2020

A division of labor: DC subsets and HIV receptor diversity

artículo científico publicado en 2002

A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments

artículo científico publicado en 2018

A needle in the 'cancer vaccine' haystack

artículo científico publicado en 2010

A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy

artículo científico publicado en 2009

A reference profile-free deconvolution method to infer cancer cell-intrinsic subtypes and tumor-type-specific stromal profiles

scientific article published on 28 February 2020

A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumab

artículo científico publicado en 2018

AACR Cancer Progress Report 2015

artículo científico publicado en 2015

ATIM-31. PHASE I STUDY OF TUMOR TREATMENT FIELDS AND A PERSONALIZED MUTATION-DERIVED TUMOR VACCINE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor

scholarly article

Abstract CT062: A Phase I study of the safety and immunogenicity of personalized mutation-derived tumor vaccine and treatment fields in patients with newly diagnosed glioblastoma

scholarly article

Abstract CT096: Phase I study of in situ autologous vaccination for prostate cancer in a neo-adjuvant setting

scholarly article

Abstract LB-194: First-in-human Phase I study of the CD40 agonist mAb CDX-1140 and in combination with CDX-301 (rhFLT3L) in patients with advanced cancers: Interim results

scholarly article

Activation and measurement of NLRP3 inflammasome activity using IL-1β in human monocyte-derived dendritic cells

artículo científico publicado en 2014

Activation of HIV-1 specific CD4 and CD8 T cells by human dendritic cells: roles for cross-presentation and non-infectious HIV-1 virus

artículo científico publicado en 2002

Activation of Toll-like receptor-2 by tumor associated matrix metalloproteinase-2 modulates dendritic cell function

artículo científico publicado en 2014

Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity

artículo científico publicado en 2003

Activation of the noncanonical NF-κB pathway by HIV controls a dendritic cell immunoregulatory phenotype.

artículo científico publicado en 2012

Activation of toll-like receptor-2 by endogenous matrix metalloproteinase-2 modulates dendritic-cell-mediated inflammatory responses.

artículo científico publicado en 2014

Active systemic lupus erythematosus is associated with decreased blood conventional dendritic cells

artículo científico publicado en 2013

Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis.

artículo científico publicado en 2018

Advances in dendritic cell immunotherapies for HIV-1 infection

artículo científico publicado en 2014

Against the self: dendritic cells versus cancer

artículo científico publicado en 2003

Amplification of low-frequency antiviral CD8 T cell responses using autologous dendritic cells

artículo científico publicado en 2002

Antigen depots: T cell traps? ⬇️

artículo científico publicado el 1 de abril de 2013

Armed and ready: how effector T cells deploy in reactive lymph nodes to modulate immunity

scientific article published on 01 July 2007

Aspirin attenuates platelet activation and immune activation in HIV-1-infected subjects on antiretroviral therapy: a pilot study

scientific article published on July 2013

Attenuated Listeria monocytogenes vectors overcome suppressive plasma factors during HIV infection to stimulate myeloid dendritic cells to promote adaptive immunity and reactivation of latent virus

artículo científico publicado en 2015

Author Correction: A conserved dendritic-cell regulatory program limits antitumour immunity

scientific article published on 05 June 2020

Autologous aldrithiol-2-inactivated HIV-1 combined with polyinosinic-polycytidylic acid-poly-L-lysine carboxymethylcellulose as a vaccine platform for therapeutic dendritic cell immunotherapy

artículo científico publicado en 2014

Bacillus Calmette-Guerin (BCG): Its fight against pathogens and cancer

artículo científico publicado en 2020

Biology of plasmacytoid dendritic cells and natural killer cells in HIV-1 infection

artículo científico publicado en 2007

CD4 Receptor is a Key Determinant of Divergent HIV-1 Sensing by Plasmacytoid Dendritic Cells.

artículo científico publicado en 2016

CD8 Epitope Escape and Reversion in Acute HCV Infection

artículo científico publicado en 2004

CD8+ T cell priming by dendritic cell vaccines requires antigen transfer to endogenous antigen presenting cells

artículo científico publicado en 2010

CSF1R inhibition depletes tumor-associated macrophages and attenuates tumor progression in a mouse sonic Hedgehog-Medulloblastoma model

artículo científico publicado en 2020

CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three cases

artículo científico publicado en 2011

Cancer immunotherapy highlights from the 2014 ASCO Meeting

Cancer immunotherapy: dendritic-cell vaccines on the move

artículo científico publicado en 2015

Cellular immune responses against CT7 (MAGE-C1) and humoral responses against other cancer-testis antigens in multiple myeloma patients.

artículo científico publicado en 2010

Changes in Frequency of HIV‐1–Specific Cytotoxic T Cell Precursors and Circulating Effectors after Combination Antiretroviral Therapy in Children

artículo científico publicado en 1999

Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells

artículo científico publicado en 2003

Clinical Trial Evidence of the Antitumor Activity of Topical Imiquimod for Breast Cancer Skin Metastases

artículo científico publicado en 2014

Clinical relevance of neutral endopeptidase (NEP/CD10) in melanoma

artículo científico publicado en 2007

Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma

scientific article published on 07 November 2019

Combining radiotherapy and immunotherapy: a revived partnership

artículo científico publicado en 2005

Computational Pipeline for the PGV-001 Neoantigen Vaccine Trial

artículo científico publicado en 2017

Computational Prediction and Validation of Tumor-Associated Neoantigens

scientific article published on 24 January 2020

Computational pipeline for the PGV-001 neoantigen vaccine trial

Converting tumors into vaccine manufacturing factories: DC recruitment, activation and clinical responses with a flt3L-primed in situ vaccine for low-grade lymphoma [nct01976585].

artículo científico publicado en 2014

Correlation of consistent blood-based gene expression with change in CTLA4 in two large independent clinical studies of patients with advanced melanoma treated with tremelimumab. ⬇️

scholarly article

Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma

artículo científico publicado en 2016

Cross-Presentation of Tumor Antigens Is Ruled by Synaptic Transfer of Vesicles among Dendritic Cell Subsets

artículo científico publicado en 2020

DC-virus interplay: a double edged sword

artículo científico publicado en 2004

DCs and NK cells: critical effectors in the immune response to HIV-1.

artículo científico publicado en 2011

Danger signals: a time and space continuum.

artículo científico publicado en 2004

Dead-cell-associated proteins are an important source of antigens for cross-presentation by dendritic cells

artículo científico publicado en 2004

Dendritic Cell Strategies for Eliciting Mutation-Derived Tumor Antigen Responses in Patients.

artículo científico publicado en 2017

Dendritic Cell Vaccines

artículo científico publicado en 2016

Dendritic cell amplification of HIV type 1-specific CD8+ T cell responses in exposed, seronegative heterosexual women.

artículo científico publicado en 2002

Dendritic cell dysregulation during HIV-1 infection

artículo científico publicado en 2013

Dendritic cell immunotherapy

artículo científico publicado en 2013

Dendritic cell subsets and locations

artículo científico publicado en 2019

Dendritic cell-based immunotherapy

artículo científico publicado en 2016

Dendritic cell-targeted approaches to modulate immune dysfunction in the tumor microenvironment

artículo científico publicado en 2013

Dendritic cells and lymphoma cells: come together right now.

artículo científico publicado en 2015

Dendritic cells and the promise of therapeutic vaccines for human immunodeficiency virus (HIV)-1.

artículo científico publicado en 2003

Dendritic cells as targets for therapy in rheumatoid arthritis

artículo científico publicado en 2009

Dendritic cells in progression and pathology of HIV infection.

artículo científico publicado en 2013

Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research.

artículo científico publicado en 2009

Differentiation of peripheral blood monocytes into dendritic cells

scientific article published on 01 July 2005

Directing dendritic cell immunotherapy towards successful cancer treatment

artículo científico publicado en 2010

Dissection of immune gene networks in primary melanoma tumors critical for antitumor surveillance of patients with stage II-III resectable disease

artículo científico

Distinguishing the immunostimulatory properties of noncoding RNAs expressed in cancer cells.

artículo científico publicado en 2015

Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Valpha24 NKT cell compartment.

artículo científico publicado en 2003

Dysregulation of anti-tumor immunity by the matrix metalloproteinase-2.

artículo científico publicado en 2012

EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer

artículo científico publicado en 2018

Efficient in vitro expansion of JC virus-specific CD8(+) T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy

artículo científico publicado en 2008

Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors

artículo científico publicado en 1996

Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions

artículo científico publicado en 2005

Evidence of dysregulation of dendritic cells in primary HIV infection

artículo científico publicado en 2010

Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.

artículo científico publicado en 2016

Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef

artículo científico publicado en 2005

Exploiting dendritic cells for active immunotherapy of cancer and chronic infection.

artículo científico publicado en 2005

Exploiting dendritic cells for active immunotherapy of cancer and chronic infections

artículo científico publicado en 2007

Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factors

artículo científico publicado en 2007

Fibroblast Growth Factor Receptor 3 Alterations and Response to PD-1/PD-L1 Blockade in Patients with Metastatic Urothelial Cancer

scientific article published on 01 July 2019

Generation of autologous peptide- and protein-pulsed dendritic cells for patient-specific immunotherapy

artículo científico publicado en 2005

Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes

artículo científico publicado en 2018

HIV type 1 infection of plasmacytoid and myeloid dendritic cells is restricted by high levels of SAMHD1 and cannot be counteracted by Vpx.

artículo científico publicado en 2013

HIV-1 impairs in vitro priming of naïve T cells and gives rise to contact-dependent suppressor T cells

artículo científico publicado en 2010

HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44

artículo científico publicado en 2012

HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism

artículo científico publicado en 2008

HLA class I - associated immunodominance affects CTL responsiveness to an ESO recombinant protein tumor antigen vaccine

artículo científico publicado en 2009

Harnessing Natural Killer Cell Function for Genitourinary Cancers

scientific article published on 02 September 2020

Harnessing the immune system to treat cancer

artículo científico publicado en 2007

Hematopoietic progenitor kinase 1 is a negative regulator of dendritic cell activation

artículo científico publicado en 2009

Host Immune Responses Against CT Antigens in Multiple Myeloma Patients. ⬇️

scholarly article

Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells

artículo científico publicado en 2004

Human immunodeficiency virus type 1 modified to package Simian immunodeficiency virus Vpx efficiently infects macrophages and dendritic cells

artículo científico publicado en 2011

Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasms

scientific article published on 02 July 2019

Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer

artículo científico publicado en 2018

Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival

artículo científico publicado en 2009

Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph node

artículo científico publicado en 2012

Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial

artículo científico publicado en 2015

Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant

artículo científico publicado en 2008

Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials

artículo científico publicado en 2016

Immunology of COVID-19: Current State of the Science

scientific article published on 06 May 2020

Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine

artículo científico publicado en 2003

Impact of MAPK Pathway Activation in BRAF(V600) Melanoma on T Cell and Dendritic Cell Function

artículo científico

Impact of chemotherapy alone, and chemotherapy plus ipilimumab, on circulating immune cells in patients with metastatic bladder cancer

artículo científico publicado en 2015

In situ vaccination for the treatment of cancer.

artículo científico publicado en 2016

In vitro priming recapitulates in vivo HIV-1 specific T cell responses, revealing rapid loss of virus reactive CD4 T cells in acute HIV-1 infection

artículo científico publicado en 2009

Influenza, but not HIV-specific CTL epitopes, elicits delayed-type hypersensitivity (DTH) reactions in HIV-infected patients

article

Inhibition of both BRAF and MEK in BRAF(V600E) mutant melanoma restores compromised dendritic cell (DC) function while having differential direct effects on DC properties.

artículo científico publicado en 2013

Innate immune responses in primary HIV-1 infection.

artículo científico publicado en 2008

Interactions between dead cells and dendritic cells in the induction of antiviral CTL responses.

artículo científico publicado en 2002

Interactions of viruses with dendritic cells

artículo científico publicado en 2001

Intratumoral checkpoint subversion as a strategy for minimizing adverse effects: Harvesting the power of TILs without harvesting TILs

artículo científico publicado en 2014

Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells

artículo científico publicado en 2020

Ion efflux and influenza infection trigger NLRP3 inflammasome signaling in human dendritic cells

artículo científico publicado en 2015

KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity

artículo científico publicado en 2008

Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction

artículo científico publicado en 2020

LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression

artículo científico publicado en 2010

Lack of Functionally Active Melan-A26–35-Specific T Cells in the Blood of HLA-A2+ Vitiligo Patients

artículo científico publicado en 2008

Lack of phenotypic and functional impairment in dendritic cells from chimpanzees chronically infected with hepatitis C virus

artículo científico publicado en 2004

Large-Scale Human Dendritic Cell Differentiation Revealing Notch-Dependent Lineage Bifurcation and Heterogeneity

artículo científico publicado en 2018

Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation

artículo científico publicado en 2022

MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivin

artículo científico publicado en 2011

Manipulating dendritic cell biology for the active immunotherapy of cancer

artículo científico publicado en 2004

Matrix metalloproteinase-2 conditions human dendritic cells to prime inflammatory T(H)2 cells via an IL-12- and OX40L-dependent pathway

artículo científico publicado en 2011

Maturation Matters: Importance of Maturation for Antitumor Immunity of Dendritic Cell Vaccines

artículo científico publicado en 2004

Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy

artículo científico publicado en 2014

Melanoma progression is associated with NK cell exhaustion.

artículo científico publicado en 2014

Modulating innate immune mechanisms to improve anti- tumor immunity

artículo científico publicado en 2017

Modulation of human Th17 cell responses through complement receptor 3 (CD11 b/CD18) ligation on monocyte-derived dendritic cells

article

Modulation of innate immunity in the tumor microenvironment

artículo científico publicado en 2016

Mutation-Derived Tumor Antigens: Novel Targets in Cancer Immunotherapy

artículo científico publicado en 2015

Mutation-derived Neoantigen-specific T-cell Responses in Multiple Myeloma

scientific article published on 19 December 2019

Oligonucleotide motifs that disappear during the evolution of influenza virus in humans increase alpha interferon secretion by plasmacytoid dendritic cells.

artículo científico publicado en 2011

P2X antagonists inhibit HIV-1 productive infection and inflammatory cytokines IL-10 and IL-1β in a human tonsil explant model

article

Pathways utilized by dendritic cells for binding, uptake, processing and presentation of antigens derived from HIV-1

artículo científico publicado en 2007

Patient-Specific Mutation-Derived Tumor Antigens As Targets for Cancer Immunotherapy in Multiple Myeloma ⬇️

scholarly article

Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes

artículo científico publicado en 2017

Phase I/II study of Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma

artículo científico publicado en 2013

Phenotypic properties of transmitted founder HIV-1

artículo científico publicado en 2013

Phosphorylated 4E-BP1 is associated with poor survival in melanoma

scientific article published on 31 March 2009

Plasma factors during chronic HIV-1 infection impair IL-12 secretion by myeloid dendritic cells via a virus-independent pathway.

artículo científico publicado en 2012

Plasmacytoid dendritic cells in HIV infection

scientific article published on January 2013

Plasmacytoid dendritic cells lead the charge against tumors

artículo científico publicado en 2012

Plasmacytoid dendritic cells: linking innate and adaptive immunity

artículo científico publicado en 2005

Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial

article

Preclinical Development of a Cord Blood (CB)-Derived Hematopoietic Stem Cell (HSC) Product for Allogeneic Transplantation in Patients with Hematological Malignancies ⬇️

artículo científico publicado en 2016

Preparation of tumor antigen-loaded mature dendritic cells for immunotherapy

artículo científico publicado en 2013

Quantitative effect of suboptimal codon usage on translational efficiency of mRNA encoding HIV-1 gag in intact T cells

artículo científico publicado en 2008

Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment

artículo científico publicado en 2018

Recent advances in dendritic cell biology

artículo científico publicado en 2005

Recent advances in dendritic cell biology

artículo científico publicado en 2005

Reply to Murali and Scolyer: Immune profile and mitotic index in advanced melanoma

artículo científico publicado en 2010

Requirement for innate immunity and CD90⁺ NK1.1⁻ lymphocytes to treat established melanoma with chemo-immunotherapy.

artículo científico publicado en 2015

Residual viral replication during antiretroviral therapy boosts human immunodeficiency virus type 1-specific CD8+ T-cell responses in subjects treated early after infection

artículo científico publicado en 2002

Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with high-risk melanoma

artículo científico publicado en 2015

Resolution of immune activation defines nonpathogenic SIV infection

artículo científico publicado en 2009

Reversal of NK-cell exhaustion in advanced melanoma by Tim-3 blockade

artículo científico publicado en 2014

Reversal of natural killer cell exhaustion by TIM-3 blockade

artículo científico publicado en 2014

Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection

artículo científico publicado en 2002

Sequence-Specific Sensing of Nucleic Acids

artículo científico publicado en 2016

Shared Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors

artículo científico publicado en 2020

Soluble CD40 ligand contributes to dendritic cell-mediated T-cell dysfunction in HIV-1 infection

artículo científico publicado en 2015

Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-α-producing and partially matured phenotype

artículo científico publicado en 2011

Structural basis for self-discrimination by neoantigen-specific TCRs

artículo científico publicado en 2024

TIM-3 and TIGIT are possible immune checkpoint targets in patients with bladder cancer

artículo científico publicado en 2020

TLR4 engagement during TLR3-induced proinflammatory signaling in dendritic cells promotes IL-10-mediated suppression of antitumor immunity

artículo científico publicado en 2011

The Human Vaccines Project: A roadmap for cancer vaccine development

artículo científico publicado en 2016

The anergic state in sarcoidosis is associated with diminished dendritic cell function

artículo científico publicado en 2008

The apoptotic-cell receptor CR3, but not alphavbeta5, is a regulator of human dendritic-cell immunostimulatory function

artículo científico publicado en 2006

The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation

artículo científico publicado en 2005

Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial

article

Therapeutic in situ autovaccination against solid cancers with intratumoral poly-ICLC: case report, hypothesis, and clinical trial

artículo científico publicado en 2014

Toll-like receptor agonists: are they good adjuvants?

artículo científico publicado en 2010

Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer

artículo científico publicado en 2012

Towards superior dendritic-cell vaccines for cancer therapy

scientific article published on 11 June 2018

Transcriptional dissection of melanoma identifies a high-risk subtype underlying TP53 family genes and epigenome deregulation

artículo científico publicado en 2017

Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA.

artículo científico publicado en 2005

Trials in progress: A phase II study of in situ therapeutic vaccination against refractory solid cancers with intratumoral poly-ICLC. ⬇️

artículo científico publicado en 2017

Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines

artículo científico publicado en 2017

Turning a Tumor into a Vaccine Factory: In Situ Vaccination for Low-Grade Lymphoma ⬇️

artículo científico publicado en 2014

Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells

artículo científico publicado en 2008

Type I interferons promote cross-priming: more functions for old cytokines

artículo científico publicado en 2003

Unexplored horizons of cDC1 in immunity and tolerance

artículo científico publicado en 2020

Unraveling predicted immunomodulatory effects of novel cancer-associated non-coding RNAs.

artículo científico publicado en 2015

Uptake and presentation of phagocytosed antigens by dendritic cells

Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming.

artículo científico publicado en 2007

Vaccination with a recombinant protein encoding the tumor-specific antigen NY-ESO-1 elicits an A2/157-165-specific CTL repertoire structurally distinct and of reduced tumor reactivity than that elicited by spontaneous immune responses to NY-ESO-1-ex

artículo científico publicado en 2009

Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire

artículo científico publicado en 2009

Whole-blood RNA transcript-based models can predict clinical response in two large independent clinical studies of patients with advanced melanoma treated with the checkpoint inhibitor, tremelimumab.

artículo científico publicado en 2017

Widespread Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors

artículo científico publicado en 2019

miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis.

artículo científico publicado en 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda